Quinolone Use during the First Trimester of Pregnancy and the Risk of Atopic Dermatitis, Asthma, and Allergies of Offspring during 2011 to 2020
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background Many pregnant women receive antibiotic treatment for infections. We investigated the association between quinolone use in the first trimester of pregnancy and the risk of adverse health outcomes for the child in Korea. Materials and Methods This nationwide, population-based cohort study used data on mother-child pairs from the National Health Insurance claims database. This study cohort included 2,177,765 pregnancies from January 1, 2011, to December 31, 2020, and 87,456 women were prescribed quinolones during pregnancy. After propensity score matching, the final number of study subjects was 84,365 for both quinolone and non-antibiotic users. We examined the subjects’ exposure to quinolone antibiotics. The main outcome measures were absolute and relative risks of atopic dermatitis, asthma, and allergies. We adjusted for potential confounders. Results Quinolones were prescribed at least once during the first trimester in 4.01% of pregnancies. Quinolone users had significantly higher absolute risks than non-antibiotic users for atopic dermatitis, asthma, and allergies, with significantly elevated risk ratios (RRs) for these conditions (atopic dermatitis: RR, 1.09; 95% confidence interval [CI], 1.08–1.11, asthma: RR, 1.04; 95% CI, 1.03–1.05, and allergies: RR, 1.10; 95% CI, 1.08–1.13). Conclusion We found that quinolone exposure during the first trimester of pregnancy increased the risk of atopic dermatitis, asthma, and allergies. This study could provide physicians with useful information when selecting antibiotics for pregnant women.
Abstract
Background Many pregnant women receive antibiotic treatment for infections. We investigated the association between quinolone use in the first trimester of pregnancy and the risk of adverse health outcomes for the child in Korea. Materials and Methods This nationwide, population-based cohort study used data on mother-child pairs from the National Health Insurance claims database. This study cohort included 2,177,765 pregnancies from January 1, 2011, to December 31, 2020, and 87,456 women were prescribed quinolones during pregnancy. After propensity score matching, the final number of study subjects was 84,365 for both quinolone and non-antibiotic users. We examined the subjects’ exposure to quinolone antibiotics. The main outcome measures were absolute and relative risks of atopic dermatitis, asthma, and allergies. We adjusted for potential confounders. Results Quinolones were prescribed at least once during the first trimester in 4.01% of pregnancies. Quinolone users had significantly higher absolute risks than non-antibiotic users for atopic dermatitis, asthma, and allergies, with significantly elevated risk ratios (RRs) for these conditions (atopic dermatitis: RR, 1.09; 95% confidence interval [CI], 1.08–1.11, asthma: RR, 1.04; 95% CI, 1.03–1.05, and allergies: RR, 1.10; 95% CI, 1.08–1.13). Conclusion We found that quinolone exposure during the first trimester of pregnancy increased the risk of atopic dermatitis, asthma, and allergies. This study could provide physicians with useful information when selecting antibiotics for pregnant women.
참고문헌 (40)
- GBD 2017 Causes of Death Collaborators, "Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017 : a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 392, pp.1736~1788 (2018)
- Sappenfield E, "Pregnancy and susceptibility to infectious diseases", Infect Dis Obstet Gynecol, 2013, pp.752852~ (2013)
- Kato H, "Systematic review and meta-analysis for impacts of oral antibiotic treatment on pregnancy outcomes in chronic endometritis patients", J Infect Chemother, 28, pp.610~615 (2022)
- Santos F, "Prevalence and predictors of anti-infective use during pregnancy", Pharmacoepidemiol Drug Saf, 19, pp.418~427 (2010)
- Chae J, "Antibiotic use during pregnancy in South Korea using 2011-2020 National Health Insurance claims data", Antibiotics(Basel), 12, pp.1242~ (2023)
- Fan H, "Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes : a systematic review and meta-analysis", PLoS One, 14, pp.e0212212~ (2019)
- Marra F, "Does antibiotic exposure during infancy lead to development of asthma? : a systematic review and metaanalysis", Chest, 129, pp.610~618 (2006)
- Omranipoor A, "Association of antibiotics therapy during pregnancy with spontaneous miscarriage : a systematic review and meta-analysis", Arch Gynecol Obstet, 302, pp.5~22 (2020)
- Zhong Y, "Maternal antibiotic exposure during pregnancy and the risk of allergic diseases in childhood : A meta-analysis", Pediatr Allergy Immunol, 32, pp.445~456 (2021)
- Zhu X, "Maternal antibiotics exposure during pregnancy and the risk of acute lymphoblastic leukemia in childhood : a systematic review and meta-analysis", Eur J Pediatr, 181, pp.471~478 (2022)
- Fan H, "Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK : population based cohort study", BMJ, 368, pp.m331~ (2020)
- Lamont RF, "Antibiotics for adverse outcomes of pregnancy", Lancet, 358, pp.1728~1729 (2001)
- Panduru M, "Antibiotics administration during last trimester of pregnancy is associated with atopic dermatitis-a cross-sectional study", Rom J Intern Med, 58, pp.99~107 (2020)
- Zheng T, "The atopic march : progression from atopic dermatitis to allergic rhinitis and asthma", Allergy Asthma Immunol Res, 3, pp.67~73 (2011)
- Björkstén B, "Worldwide time trends for symptoms of rhinitis and conjunctivitis : phase III of the International study of asthma and allergies in childhood", Pediatr Allergy Immunol, 19, pp.110~124 (2008)
- Mathiesen SM, "The prevalence of atopic dermatitis in adults : systematic review on population studies", Dermatol Online J, 25, pp.13030 (2019), qt6nj0x5k0~
- Chiesa Fuxench ZC, "Atopic dermatitis in America study : a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population", J Invest Dermatol, 139, pp.583~590 (2019)
- Silverberg JI, "Associations of childhood eczema severity : a US population-based study", Dermatitis, 25, pp.107~114 (2014)
- Song P, "Global, regional, and national prevalence of asthma in 2019 : a systematic analysis and modelling study", J Glob Health, 12, pp.04052~ (2022)
- Mallol J, "The International Study of Asthma and Allergies in Childhood(ISAAC)phase three : a global synthesis", Allergol Immunopathol(Madr), 41, pp.73~85 (2013)
- Peters RL, "The prevalence of food allergy and other allergic diseases in early childhood in a population-based study : HealthNuts age 4-year follow-up", J Allergy Clin Immunol, 140, pp.145~153 (2017)
- Bar-Oz B, "The safety of quinolones--a meta-analysis of pregnancy outcomes", Eur J Obstet Gynecol Reprod Biol, 143, pp.75~78 (2009)
- Yefet E, "The safety of quinolones and fluoroquinolones in pregnancy : a meta-analysis", BJOG, 125, pp.1069~1076 (2018)
- Lee E, "Associations of prenatal antibiotic exposure and delivery mode on childhood asthma inception", Ann Allergy Asthma Immunol, 131, pp.52~58 (2023)
- Uldbjerg CS, "Antibiotic exposure during pregnancy and childhood asthma : a national birth cohort study investigating timing of exposure and mode of delivery", Arch Dis Child, 106, pp.888~894 (2021)
- Metzler S, "Association between antibiotic treatment during pregnancy and infancy and the development of allergic diseases", Pediatr Allergy Immunol, 30, pp.423~433 (2019)
- Okoshi K, "Maternal antibiotic exposure and childhood allergies : the Japan environment and children's study", J Allergy Clin Immunol Glob, 2, pp.100137~ (2023)
- Park D, "High-cost users of prescription drugs : National Health Insurance data from South Korea", J Gen Intern Med, 37, pp.2390~2397 (2022)
- World Health Organization Collaborating Centres (WHOCC), "Anatomical therapeutic chemical (ATC)", defined daily dose (DDD) index, 2020
- Stelmach I, "Risk factors for the development of atopic dermatitis and early wheeze", Allergy Asthma Proc, 35, pp.382~389 (2014)
- Azad MB, "Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life : a prospective cohort study", BJOG, 123, pp.983~993 (2016)
- Aboubakr M, "Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats", Adv Pharmacol Sci, 2014, pp.924706~ (2014)
- Hooper DC, "Mechanisms of action of antimicrobials : focus on fluoroquinolones", Clin Infect Dis, 32(Suppl 1), pp.S9~S15 (2001)
- Fishman E, "Association between early-childhood antibiotic exposure and subsequent asthma in the US Medicaid population", Ann Allergy Asthma Immunol, 123, pp.186~192 (2019)
- Mori K, "Mechanism of histamine release induced by levofloxacin, a fluoroquinolone antibacterial agent", Eur J Pharmacol, 394, pp.51~55 (2000)
- Ziv A, "Pregnancy outcomes following exposure to quinolone antibiotics-a systematic-review and meta-analysis", Pharm Res, 35, pp.109~ (2018)
- Bai L, "Trimester-specific association between antibiotics exposure during pregnancy and childhood asthma or wheeze : the role of confounding", Ann Epidemiol, 30, pp.1~8 (2019)
- Noh Y, "First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring : a population-based cohort study in South Korea", PLoS Med, 19, pp.e1003945~ (2022)
- Park J, "Health care utilization and anti-cancer drug expenditure for six solid cancers in Korea from 2007 to 2019", Front Oncol, 12, pp.862173~ (2022)
- Oh JY, "Trends in orphan drug use and spending among children and adolescents during 2010-2020 in Korea", Front Pharmacol, 13, pp.964426~ (2022)